June 10, 2020
June 10, 2020
PHILADELPHIA – Integral Molecular, the leader in discovering and characterizing antibodies against membrane protein and viral targets, is applying its Membrane Proteome Array (MPA) technology for […]
April 30, 2020
April 30, 2020
PHILADELPHIA – Integral Molecular announces the launch of SARS-CoV-2 Reporter Virus Particles (RVPs) to test patients for the presence of neutralizing antibodies, determine the effectiveness of […]
April 21, 2020
April 21, 2020
PHILADELPHIA – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms […]
March 9, 2020
March 9, 2020
PHILADELPHIA –Integral Molecular announces the mobilization of two of its key technology platforms to aid in the discovery of vaccines and therapeutics against the novel coronavirus […]
February 12, 2020
February 12, 2020
PHILADELPHIA –Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces the launch of ReadyMap services, an expansion of its […]
January 8, 2020
January 8, 2020
PHILADELPHIA – Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against P2X7, a structurally complex ion channel that […]
November 14, 2019
November 14, 2019
PHILADELPHIA – (PR NEWSWIRE) – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular a contract (75N93019C00073) which will provide up to […]
October 18, 2019
October 18, 2019
PHILADELPHIA – (PR NEWSWIRE) – Integral Molecular, the industry leader in membrane protein solutions, has expanded its research facility to a second location to accommodate an […]
September 26, 2019
September 26, 2019
PHILADELPHIA ¬ Sept. 26, 2019 — Integral Molecular, Inc. has been selected by The Wistar Institute, a global leader in cancer, immunology and infectious disease research […]